1-6 of 6
P.W. Wijermans, MD,PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Escalated Dose Bortezomib Once Weekly Combined with Lenalidomide and Dexamethasone (eVRD) Followed by Lenalidomide Maintenance in First Relapse of Multiple Myeloma (MM). the HOVON 86 Phase 2 Trial

Pieter Sonneveld, MD, Okke de Weerdt, Mark-David Levin, Wendimagegn Ghidey, Edo Vellenga, Saskia K Klein, Jeanette Doorduyn, Marie José Kersten, P.W. Wijermans, MD, PhD, Henk Lokhorst, MD
Journal: Blood
Blood (2012) 120 (21): 1853.
https://doi.org/10.1182/blood.V120.21.1853.1853
Published: 2012
Journal Articles

Platelet Doubling After the First Azacitidine Cycle Is a Promising Predictor for Response in MDS, CMML and AML Patients in the Dutch Azacitidine Compassionate Patient Named Program,

Geert A Huls, Lieke H. van der Helm, Canan Alhan, P.W. Wijermans, MD, PhD, Marinus van Marwijk Kooy, Martijn R. Schaafsma, Bart J Biemond, MD, Aart Beeker, Mels Hoogendoorn, Bastiaan P. van Rees, Okke de Weerdt, Jurgen Wegman, Eduard J Libourel, Sylvia A. Luykx-de Bakker, Monique C. Minnema, MD PhD, Rolf Brouwer, Fransien Croon-de Boer, Matthias Eefting, Kon-Siong G. Jie, Arjan A. van der Loosdrecht, Jan Koedam, Nic J.G.M. Veeger, Edo Vellenga, PhD
Journal: Blood
Blood (2011) 118 (21): 3841.
https://doi.org/10.1182/blood.V118.21.3841.3841
Published: 2011
Journal Articles

A Phase 2 Multicenter Study of Siltuximab, An Anti-IL-6 Monoclonal Antibody, in Patients with Relapsed or Refractory Multiple Myeloma,

Peter M. Voorhees, MD, Robert F Manges, MD, Pieter Sonneveld, MD, PhD, Sundar Jagannath, MD, George Somlo, MD, Amrita Krishnan, MD, Suzanne Lentzsch, MD, PhD, Richard C Frank, MD, Sonja Zweegman, MD, PhD, P.W. Wijermans, MD, PhD, Britte Rijnbeek, Xiang Qin, PhD, Mark J. Cornfeld, MD, MPH, Hong Xie, MD, MS, MBA, Sheeba K. Thomas, MD
Journal: Blood
Blood (2011) 118 (21): 3971.
https://doi.org/10.1182/blood.V118.21.3971.3971
Published: 2011
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Improves Outcome As Compared to Conventional Consolidation in Patients Aged 40–60 Years with AML in CR1 with Apparent Greater Benefit for Reduced Intensity Rather Than Myeloablative Conditioning

Jan J Cornelissen, MD PhD, Alois Gratwohl, MD, Kees GM van Montfort, Thomas Pabst, MD, Johan Maertens, MD, H. Berna Beverloo, PhD, Marinus van Marwijk Kooy, P.W. Wijermans, MD, PhD, Bart J Biemond, MD, Dimitri A. Breems, MD, PhD, Edo Vellenga, PhD, Leo F Verdonck, Martin F. Fey, MD, Mojca Lavrencic, MD, PhD, Jeroen JWM Janssen, MD PhD, Gerwin Huls, Jurgen Kuball, MD, PhD, Jakob R. Passweg, MD, Carlos Graux, MD, PhD, Harry C. Schouten, MD, PhD, Gert Ossenkoppele, MD, PhD, Bob Lowenberg, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 159.
https://doi.org/10.1182/blood.V118.21.159.159
Published: 2011
Journal Articles

Mobilisation of Autologous Stem Cells Using a Single Fixed Dose Injection of Pegfilgrastim; Feasibility in Extensively Pre-Treated Lymphoma and Myeloma Patients.

Paula F. Ypma, MD, Arif A. Muradin, P.W. Wijermans, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 5220.
https://doi.org/10.1182/blood.V108.11.5220.5220
Published: 2006
Journal Articles

Isovolemic Erythrocytapheresis; Fixed Versus Patient Tailored Volume Exchange in Patients with Polycythemia or Hemochromatosis.

P.W. Wijermans, MD, PhD, L. van Egmond, P.F. Ypma, MD, M.R. Schipperus, MD PhD, Jean-Louis Kerkhoffs, MD, L.H. Bohmer, MD
Journal: Blood
Blood (2006) 108 (11): 4894.
https://doi.org/10.1182/blood.V108.11.4894.4894
Published: 2006